SAM

Sectoral Asset Management Portfolio holdings

AUM $162M
1-Year Est. Return 44.84%
This Quarter Est. Return
1 Year Est. Return
+44.84%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$162M
AUM Growth
+$10.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
98
New
Increased
Reduced
Closed

Top Buys

1
+$5.4M
2
+$4.77M
3
+$3.41M
4
ANAB icon
AnaptysBio
ANAB
+$3.39M
5
IMTX icon
Immatics
IMTX
+$1.94M

Top Sells

1
+$28.6M
2
+$13.2M
3
+$4.05M
4
PVLA
Palvella Therapeutics
PVLA
+$2.92M
5
REPL icon
Replimune Group
REPL
+$2.15M

Sector Composition

1 Healthcare 97.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JAZZ icon
76
Jazz Pharmaceuticals
JAZZ
$10.3B
$296K 0.18%
2,244
-30
ILMN icon
77
Illumina
ILMN
$21.6B
$259K 0.16%
2,727
-55
INCY icon
78
Incyte
INCY
$20.9B
$257K 0.16%
3,030
-3,030
PCVX icon
79
Vaxcyte
PCVX
$6.1B
$151K 0.09%
4,205
MRNA icon
80
Moderna
MRNA
$16.3B
$145K 0.09%
5,600
AXSM icon
81
Axsome Therapeutics
AXSM
$8.94B
$124K 0.08%
1,020
MLTX icon
82
MoonLake Immunotherapeutics
MLTX
$1.19B
$6.86K ﹤0.01%
956
-14,152
CNC icon
83
Centene
CNC
$22.5B
– –
-12,500
CRSP icon
84
CRISPR Therapeutics
CRSP
$5.1B
– –
-2,540
CVRX icon
85
CVRx
CVRX
$137M
– –
-73,500
RVMD icon
86
Revolution Medicines
RVMD
$23.3B
– –
-6,240
RXRX icon
87
Recursion Pharmaceuticals
RXRX
$2.43B
– –
-11,500
SRRK icon
88
Scholar Rock
SRRK
$4.59B
– –
-10,380
TRML
89
DELISTED
Tourmaline Bio
TRML
– –
-116,510
VTRS icon
90
Viatris
VTRS
$14.8B
– –
-19,800
LENZ
91
LENZ Therapeutics
LENZ
$572M
– –
-977,245
KMTS
92
Kestra Medical Technologies
KMTS
$1.33B
– –
-35,000
CAI
93
Caris Life Sciences
CAI
$7.56B
– –
-8,350
GMED icon
94
Globus Medical
GMED
$12.5B
– –
-13,500
IOBT icon
95
IO Biotech
IOBT
$36.1M
– –
-117,691
LEGN icon
96
Legend Biotech
LEGN
$4.09B
– –
-19,627
MEDP icon
97
Medpace
MEDP
$17.2B
– –
-531
REPL icon
98
Replimune Group
REPL
$552M
– –
-231,650
1 2 3
4